Ameriprise’s Evolus EOLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $226K | Buy |
32,545
+1,910
| +6% | +$11.3K | ﹤0.01% | 3926 |
|
|
2026
Q1 | $126K | Sell |
30,635
-23,635
| -44% | -$115K | ﹤0.01% | 3938 |
|
|
2025
Q4 | $361K | Sell |
54,270
-3,062
| -5% | -$20.7K | ﹤0.01% | 3743 |
|
|
2025
Q3 | $352K | Sell |
57,332
-506
| -0.9% | -$3.95K | ﹤0.01% | 3737 |
|
|
2025
Q2 | $533K | Sell |
57,838
-7,977
| -12% | -$81.6K | ﹤0.01% | 3508 |
|
|
2025
Q1 | $792K | Sell |
65,815
-14,631
| -18% | -$191K | ﹤0.01% | 3300 |
|
|
2024
Q4 | $888K | Buy |
80,446
+8,214
| +11% | +$116K | ﹤0.01% | 3295 |
|
|
2024
Q3 | $1.17M | Sell |
72,232
-10,992
| -13% | -$154K | ﹤0.01% | 3154 |
|
|
2024
Q2 | $903K | Sell |
83,224
-10,167
| -11% | -$125K | ﹤0.01% | 3193 |
|
|
2024
Q1 | $1.31M | Sell |
93,391
-17,748
| -16% | -$231K | ﹤0.01% | 3064 |
|
|
2023
Q4 | $1.17M | Sell |
111,139
-13,317
| -11% | -$119K | ﹤0.01% | 3124 |
|
|
2023
Q3 | $1.14M | Buy |
124,456
+93,185
| +298% | +$836K | ﹤0.01% | 3079 |
|
|
2023
Q2 | $227K | Buy |
31,271
+340
| +1% | +$2.93K | ﹤0.01% | 3695 |
|
|
2023
Q1 | $262K | Sell |
30,931
-1,300
| -4% | -$11.8K | ﹤0.01% | 3652 |
|
|
2022
Q4 | $242K | Buy |
32,231
+990
| +3% | +$7.67K | ﹤0.01% | 3658 |
|
|
2022
Q3 | $251K | Sell |
31,241
-380
| -1% | -$4.03K | ﹤0.01% | 3640 |
|
|
2022
Q2 | $367K | Sell |
31,621
-1,090
| -3% | -$12.9K | ﹤0.01% | 3499 |
|
|
2022
Q1 | $367K | Buy |
32,711
+720
| +2% | +$6.14K | ﹤0.01% | 3579 |
|
|
2021
Q4 | $208K | Sell |
31,991
-3,510
| -10% | -$24.1K | ﹤0.01% | 3781 |
|
|
2021
Q3 | $271K | Sell |
35,501
-1,723
| -5% | -$17.8K | ﹤0.01% | 3612 |
|
|
2021
Q2 | $471K | Buy |
37,224
+3,350
| +10% | +$36.8K | ﹤0.01% | 3477 |
|
|
2021
Q1 | $440K | Sell |
33,874
-300
| -0.9% | -$2.76K | ﹤0.01% | 3456 |
|
|
2020
Q4 | $115K | Sell |
34,174
-3,197
| -9% | -$12K | ﹤0.01% | 3677 |
|
|
2020
Q3 | $146K | Sell |
37,371
-2,530
| -6% | -$9.24K | ﹤0.01% | 3601 |
|
|
2020
Q2 | $211K | Buy |
39,901
+2,485
| +7% | +$11.4K | ﹤0.01% | 3479 |
|
|
2020
Q1 | $155K | Sell |
37,416
-639
| -2% | -$5.42K | ﹤0.01% | 3479 |
|
|
2019
Q4 | $463K | Sell |
38,055
-2,927
| -7% | -$41.3K | ﹤0.01% | 3358 |
|
|
2019
Q3 | $640K | Buy |
40,982
+1,475
| +4% | +$24.2K | ﹤0.01% | 3213 |
|
|
2019
Q2 | $578K | Sell |
39,507
-226
| -0.6% | -$4.48K | ﹤0.01% | 3276 |
|
|
2019
Q1 | $897K | Buy |
+39,733
| New | +$859K | ﹤0.01% | 3089 |
|
Other funds holding EOLS
Ameriprise's EOLS Position: Q2 2026 in Review
Ameriprise increased its Evolus (EOLS) stake by 6.2% in Q2 2026, buying an estimated $11.3K and bringing the position to 32,545 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #3926.
Ameriprise first reported a position in EOLS in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.31M in Q1 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.
- Ameriprise held 32,545 shares of Evolus worth $226K as of Q2 2026.
- Ameriprise bought 1,910 Evolus shares in Q2 2026, an estimated $11.3K.
- Evolus made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #3926 holding.
- Ameriprise first reported a position in Evolus in Q1 2019 and has held it in 30 quarters since.
- Ameriprise's Evolus position peaked at $1.31M in Q1 2024.
- 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.